October 5th, 2018
Sharp, a global leader in contract packaging and clinical supply services, has formed a long-term, strategic partnership with Santen Pharmaceuticals to provide pharmaceutical packaging services from Heerenveen in the Netherlands.
Santen is a leading global pharmaceutical company providing treatment for a broad range of ophthalmic diseases including glaucoma and dry eye disease.
Sharp will provide secondary packaging services for Santen’s ophthalmic products using dedicated bottle and ampoule labeling lines, all of which will comply with all applicable regulatory requirements, including serialization.
Roel Kerkhof, General Manager of Sharp Europe said: “The partnership with Santen will ensure it benefits from state-of-the-art services, offering increased supply chain efficiency, cost savings and a central European location which simplifies access to EU markets”.
As a specialized company dedicated to the ophthalmic field, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products and devices. Santen has long been the market leader in Japan for prescription ophthalmic pharmaceuticals and is now a leader in the sector in the EMEA (Europe, Middle East and Africa) region. With scientific knowledge and organizational capabilities nurtured over nearly 130 years, Santen products and services now reach over 60 countries, contributing to the well-being of patients, their loved ones and consequently to society.
For more information, please visit Santen websites www.santen.com (Japan headquarters) and www.santen.eu (EMEA).